<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Arch Pharm Pract</journal-id>
      <journal-id journal-id-type="publisher-id">archivepp.com</journal-id>
      <journal-id journal-id-type="publisher-id">Arch Pharm Pract</journal-id>
      <journal-title-group>
        <journal-title>Archives of Pharmacy Practice</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2320-5210</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">archivepp.com-1229</article-id>
      <article-id pub-id-type="doi">10.51847/3SunDca4wi</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Risk of Renal Failure in Family Members of Dialysis Patients: Implication of Surveillance and Awareness Activities</article-title>
      </title-group>
                    <contrib-group>
                      <contrib contrib-type="author">
              <name>
                <surname>Cholamugath</surname>
                <given-names>Shinu</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                                            <xref rid="cor1" ref-type="corresp" />
                          </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Shanavas</surname>
                <given-names>Fathima</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Sahla</surname>
                <given-names>Fathimath</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Rahman</surname>
                <given-names>Hafees</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                      <contrib contrib-type="author">
              <name>
                <surname>Rayammarakkar</surname>
                <given-names>Hamna</given-names>
              </name>
                              <xref rid="aff1" ref-type="aff">1</xref>
                                        </contrib>
                  </contrib-group>
                  <aff id="aff1">
            <label>1</label>Department of Pharmacy Practice, Al Shifa College of Pharmacy, Perinthalmanna, Kerala, India.
          </aff>
                          <author-notes>
            <corresp id="cor1">
              <bold>Address for correspondence:</bold> Prof. Wael Abu Dayyih, Department of
              Pharmaceutical Chemistry, Faculty of Pharmacy, Mutah University, Al-Karak 61710, Jordan.
                              E-mail: <email xlink:href="shinu.c1@gmail.com">shinu.c1@gmail.com</email>
                          </corresp>
          </author-notes>
                    <pub-date pub-type="epub">
        <day>19</day>
        <month>05</month>
        <year>2025</year>
      </pub-date>
      <volume>16</volume>
      <issue>2</issue>
      <fpage>1</fpage>
      <lpage>5</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Archives of Pharmacy Practice
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>A prospective observational study was conducted to identify high-risk populations for chronic kidney disease, create awareness through public education, and reduce the disease burden. Active screening was performed on 714 participants, including 357 first-degree relatives of patients with chronic kidney disease as the test group and 357 spouses as the control group. The test group showed higher average values for systolic blood pressure (140.10 ± 19.38 millimeters of mercury) and diastolic blood pressure (86.23 ± 5.11 millimeters of mercury) compared to the control group (123.70 ± 7.13 millimeters of mercury and 75.13 ± 4.91 millimeters of mercury, respectively). Fasting blood sugar levels and serum creatinine levels were elevated in the test group (2.10 ± 6.66 milligrams per deciliter) compared to the control group (0.93 ± 0.35 milligrams per deciliter). Additionally, the average urine albumin level in the test group (26.05 ± 8.04 milligrams) and the albumin-to-creatinine ratio were significantly higher than in the control group (13.23 ± 2.80 milligrams).

The study findings indicated that individuals with a family history of kidney failure, especially first-degree relatives, are at an increased risk of developing kidney disease compared to those without such a history. This emphasizes the importance of familial predisposition as a significant risk factor. Despite this, awareness of kidney disease was observed to be low among participants, highlighting the urgent need for targeted education and early screening programs to prevent the progression of kidney disease in high-risk groups. </p>
      </abstract>
      <kwd-group>
                <kwd>Chronic kidney disease</kwd>
                <kwd>Family history</kwd>
                <kwd>Hereditary</kwd>
                <kwd>Awareness</kwd>
              </kwd-group>
    </article-meta>
  </front>
</article>